Your browser doesn't support javascript.
loading
Factors associated with private or public breast cancer screening attendance in Queensland, Australia: A retrospective cross-sectional study.
Li, Tong; Marinovich, M Luke; Ormiston-Smith, Nick; Nickel, Brooke; Findlay, Andrea; Houssami, Nehmat.
Afiliação
  • Li T; The Daffodil Centre, The University of Sydney, a joint venture with Cancer Council NSW, Sydney, New South Wales, Australia.
  • Marinovich ML; The Daffodil Centre, The University of Sydney, a joint venture with Cancer Council NSW, Sydney, New South Wales, Australia.
  • Ormiston-Smith N; Cancer Screening Unit, Queensland Public Health and Scientific Services Division, Queensland Health, Brisbane, Queensland, Australia.
  • Nickel B; School of Public Health, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.
  • Findlay A; Cancer Screening Unit, Queensland Public Health and Scientific Services Division, Queensland Health, Brisbane, Queensland, Australia.
  • Houssami N; The Daffodil Centre, The University of Sydney, a joint venture with Cancer Council NSW, Sydney, New South Wales, Australia.
J Med Screen ; : 9691413241248528, 2024 Jun 07.
Article em En | MEDLINE | ID: mdl-38850032
ABSTRACT
This study aimed to estimate participation in private breast screening in Queensland, Australia, where public-funded screening is implemented, and to identify factors associated with the screening setting, using an online survey (999 female respondents aged 40-74). Screening-specific and socio-demographic factors were collected. Multivariable logistic regression was used to identify factors associated with screening setting (public vs private) and screening recency (<2 vs ≥2 years). Participation estimates were 53.2% (95% confidence interval, CI 50.0%-56.3%) and 10.9% (9.0%-13.0%) for national screening program and private screening, respectively. In the screening setting model, participation in private screening was significantly associated with longer time since last screening (>4 versus <2 years, odds ratio (OR) = 7.3, 95%CI 4.1-12.9, p < 0.001), having symptoms (OR = 9.5, 5.8-15.5, p < 0.001), younger age (40-49 versus 50-74 years, OR = 1.8, 1.1-3.0, p = 0.018) and having children <18 years in household (OR = 2.4, 1.5-3.9, p < 0.001). In the screening recency model, only screening setting was statistically significant and private screening was associated with screening recency ≥2 years (OR = 4.0, 2.8-5.7, p < 0.001). Around one in nine women screen outside of the BreastScreen Queensland program. Clinical and socio-demographic factors associated with participation in private screening were identified, providing knowledge relevant to the program's endeavours to improve screening participation.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: J Med Screen Assunto da revista: EPIDEMIOLOGIA / SAUDE PUBLICA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Austrália

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: J Med Screen Assunto da revista: EPIDEMIOLOGIA / SAUDE PUBLICA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Austrália